Blog

“The Big 3” – A Financial and Pipeline Analysis of $ATAI, $CMPS, and $MNMD

Jun 2 • 1 min read

As a follow-up to our last “big 3” comparison, Psychedelic Invest’s very own Adam Tubero provides an updated comparative analysis of Mind Medicine ($MNMD), atai Life Sciences ($ATAI), and Compass Pathways ($CMPS). In the below video, Adam provides a deep dive comparing the financials and the pipelines of these three companies. All of the information…

Awakn Life Sciences Initiates Follow-On Behavioral Study to Focus on Gambling Disorder

Jun 2 • 3 min read

Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a biotechnology company, researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), announced today that they have initiated a larger behavioral addiction study investigating ketamine as a treatment for Gambling Disorder. Awakn announced on May…

Clearmind Medicine Granted Patent Approval for Psychedelic- Based Alcohol Substitute in India

Jun 1 • 2 min read

Clearmind Medicine Inc. (CSE: CMND | OTC Pink: CMNDF | FSE: CWY0), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, has been granted patent approval from the Office of the Controller-General of Patents, Designs and Trademarks in India. The patent refers to the company’s proprietary…

Hadas Alterman & Adriana Kertzer are Humanizing the Legal Process for Psychedelics – Podcast Episode #6

Jun 1 • 1 min read

On the sixth episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Hadas Alterman and Adriana Kertzer of the Plant Medicine Law Group. During the conversation, they uncover the importance of the work they’re doing for the industry and pave the legal path for the mass adoption of psychedelics. New episodes of…

Mydecine Announces Closing of Overnight Marketed Public Offering of Units

May 30 • 3 min read

Mydecine Innovations Group Inc. (NEO: MYCO | OTC: MYCOF | FSE: 0NFA) is pleased to announce that it has closed its previously announced best efforts overnight marketed offering of units through a syndicate of agents led by Stifel Nicolaus Canada Inc. and Roth Canada, Inc. Under the Offering, the Company issued 2,447,130 Units at a…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538